ICH: Adoption of the ICH Q1 Stability Guideline
The Assembly of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) met on 17-18 November 2026 in Prague, Czechia for its biannual meeting.
ICH announced, among other things, adoption of ICH Q1: Stability Testing of Drug Substances and Drug Products as a final harmonised guideline. This foundational guideline will supersede seven current guidelines: the ICH Q1A-Q1F series and ICH Q5.
The text will be published in the coming weeks; detailed changes and regional implementation dates therefore remain to be assessed.
For more information, read our LOGFILE feature “The Draft ICH Q1 Guideline: A Fresh Take on Stability”. In it, Joachim Ermer summarises the most significant changes and comments on critical aspects of the draft.
Source:
ICH: Key Outcomes of Biannual ICH Assembly Meeting in Prague
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.